Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 8/20 | 0.50 |
| ▸ | ACLY | P53396 | 2/20 | 0.46 |
| ▸ | ACACA | Q13085 | 2/20 | 0.46 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.43 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | EBP | Q15125 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1874653 | 0.86 | ACLY (0.48) | HSD11B1ACLYACACAPTPN11HSD11B2 | |
| SCHEMBL1878720 | 0.84 | ACLY (0.63) | HSD11B1ACLYACACAPTPN11HSD11B2 | |
| SCHEMBL14520017 | 0.84 | ACLY (0.63) | HSD11B1ACLYACACAPTPN11HSD11B2 | |
| SCHEMBL13801861 | 0.84 | ACLY (0.63) | HSD11B1ACLYACACAPTPN11HSD11B2 | |
| SCHEMBL14047057 | 0.84 | ACLY (0.63) | HSD11B1ACLYACACAPTPN11HSD11B2 | |
| SCHEMBL12152345 | 0.84 | ACLY (0.63) | HSD11B1ACLYACACAPTPN11HSD11B2 | |
| SCHEMBL13420256 | 0.84 | ACLY (0.63) | HSD11B1ACLYACACAPTPN11HSD11B2 | |
| SCHEMBL982765 | 0.84 | ACLY (0.63) | HSD11B1ACLYACACAPTPN11HSD11B2 | |
| SCHEMBL1878721 | 0.84 | ACLY (0.63) | HSD11B1ACLYACACAPTPN11HSD11B2 | |
| SCHEMBL13455191 | 0.84 | ACLY (0.63) | HSD11B1ACLYACACAPTPN11HSD11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 675 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117460535-A | Composition based on monoacylglycerols and free fatty acids, method for the production and use thereof | 格雷科斯生物股份有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-110300575-B | Extract of celastrus orbiculatus rattan, cosmetic composition comprising same and cosmetic use thereof | ISP投资有限公司 | 2022-11-15 | — | — | CN | claimed |
| EP-2767172-B1 | FAT COMPOSITION | KAO CORP (JP) | 2022-06-08 | — | — | EP | claimed |
| EP-2656737-B1 | FAT AND/OR OIL COMPOSITION | KAO CORP (JP) | 2019-04-24 | — | — | EP | claimed |
| EP-2641475-B1 | OIL OR FAT COMPOSITION | KAO CORP (JP) | 2018-03-28 | — | — | EP | claimed |
| EP-2749177-B1 | OIL/FAT COMPOSITION | KAO CORP (JP) | 2017-03-29 | — | — | EP | claimed |
| EP-3120854-A1 | CYCLOARTENOL-CONTAINING COMPOSITION | Kao Corporation (JP) | 2017-01-25 | — | — | EP | claimed |
| US-20170014430-A1 | Cycloartenol-Containing Composition | KAO CORPORATION (JP) | 2017-01-19 | — | — | US | claimed |
| EP-2749176-B1 | OIL/FAT COMPOSITION | KAO CORP (JP) | 2016-08-10 | — | — | EP | claimed |
| US-9399041-B2 | Fat composition | KAO CORPORATION (JP) | 2016-07-26 | — | — | US | claimed |
| WO-2004095926-A2 | TREATMENT OF PLANTS AND PLANT PROPAGATION MATERIALS WITH AN ANTIOXIDANT TO IMPROVE PLANT HEALTH AND/OR YIELD | MONSANTO TECHNOLOGY, LLC (US) | 2004-11-11 | — | — | WO | claimed |
| WO-2004050208-A1 | METHOD OF EXTRACT COMPOSITION CONTROL IN PEAT EXTRACTION, PEAT EXTRACT, AND USE OF PEAT EXTRACT | AROMTECH LTD (FI) | 2004-06-17 | — | — | WO | claimed |
| EP-1426028-A1 | Method of extract composition control in peat extraction, peat extract, and use of peat extract | Aromtech Ltd (FI) | 2004-06-09 | — | — | EP | claimed |
| JP-2004504291-A | — | — | 2004-02-12 | — | — | JP | claimed |
| US-20030195367-A1 | Method for preparing a fatty substance ester and use thereof in pharmaceutics, cosmetics or food industry | LABORATOIRES EXPANSCIENCE (FR) | 2003-10-16 | — | — | US | claimed |
| EP-1301460-A1 | METHOD FOR PREPARING A FATTY SUBSTANCE ESTER AND USE THEREOF IN PHARMACEUTICS, COSMETICS OR FOOD INDUSTRY | Laboratoires Expanscience (FR) | 2003-04-16 | — | — | EP | claimed |
| WO-2002006205-B1 | METHOD FOR PREPARING A FATTY SUBSTANCE ESTER AND USE THEREOF IN PHARMACEUTICS, COSMETICS OR FOOD INDUSTRY | PHARMASCIENCE LAB (FR) | 2002-03-21 | — | — | WO | claimed |
| WO-2002006205-A1 | METHOD FOR PREPARING A FATTY SUBSTANCE ESTER AND USE THEREOF IN PHARMACEUTICS, COSMETICS OR FOOD INDUSTRY | LABORATOIRES EXPANSCIENCE (FR) | 2002-01-24 | — | — | WO | claimed |
| US-4748161-A | Triterpenyl esters of organic acids and hypolipidemic agents composed of them | AMANO PHARMACEUTICAL CO., LTD. (JP) | 1988-05-31 | — | — | US | claimed |
| EP-0166542-A2 | Triterpenyl esters of organic acids, process for their production, and hypolipidemic agents composed of them | AMANO PHARMACEUTICAL CO., LTD. (JP) | 1986-01-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030195367-A1 | Method for preparing a fatty substance ester and use thereof in pharmaceutics, cosmetics or food industry | LSS, CYP51A1, CYP46A1 | HSD11B1 8/4885ACLY 2551/4885ACACA 1616/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.